The MTS and Transwell assays SW480 cells with knockdown ZEB2 by siRNA were used to investigate whether MEF2A affects CRC motility by promoting the expression of ZEB2 (Supplementary Fig. S5a, b). The gene discussed is ZEB2; the disease is colorectal carcinoma.